Tristel PLC is a UK‐based specialist in infection prevention and contamination control, listed on the OTC Markets as TSNLF. The company develops, manufactures and distributes chlorine dioxide–based cleaning, disinfection and sterilization solutions aimed primarily at healthcare, life-science and pharmaceutical markets. Its products are designed to deliver broad‐spectrum antimicrobial efficacy against bacteria, viruses and spores while minimizing corrosiveness and environmental impact.
Tristel’s core product portfolio includes wipe and spray formats for sporicidal surface disinfection, rinse-free instrument and endoscope reprocessing systems, and probe covers and gels for ultrasound devices. These solutions are formulated to meet rigorous regulatory standards, offering validated contact times and material compatibility across a range of clinical and clean-environment applications.
The company operates through a network of direct sales offices and independent distributors, serving hospitals, outpatient clinics, dental practices and GMP-regulated pharmaceutical facilities in over 80 countries. Regional hubs in Europe, North America and Asia Pacific support localized customer training, technical service and regulatory compliance.
Founded in the early 1990s, Tristel has grown through ongoing investment in research and development, strategic partnerships and regulatory approvals. The executive team combines expertise in microbiology, regulatory affairs and manufacturing, guiding the company’s expansion of product offerings and geographic reach while maintaining a focus on safety and efficacy in infection control.
AI Generated. May Contain Errors.
MarketBeat All Access